CLINICAL_TRIALS
withdrawal
· 2021-09-29
Clinical Trial Update: Intraabdominal Chloroprocaine During Cesarean Delivery for Pain Control [Phase 3]
Summary
Phase 3 trial on intraabdominal chloroprocaine for pain control during cesarean delivery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Cesarean Section Complications, Pain | Phase 3 | Status: WITHDRAWN